Literature DB >> 12522882

[Medical birth registry--an essential resource in perinatal medical research].

Lorentz M Irgens1.   

Abstract

Based on compulsory notification and operative since 1967 the Medical Birth Registry of Norway comprises all births in the country after 16 weeks gestation. The notification form is filled in by the midwife and the doctor and contains civil data on mother, father and the newborn as well as medical data on mother's health before and during the pregnancy, on the birth, including complications, and on the newborn, including birth defects and other congenital conditions. All diagnoses recorded before discharge from the hospital are included. From 1998, diagnoses recorded after transfer to a paediatric department and throughout the first year of life are notified as well. The registry data are used for epidemiological surveillance of birth defects and other perinatal health problems, for evaluation of health services and as a basis for perinatal epidemiological research; follow-up studies based on internal and external record linkage are essential.

Entities:  

Mesh:

Year:  2002        PMID: 12522882

Source DB:  PubMed          Journal:  Tidsskr Nor Laegeforen        ISSN: 0029-2001


  9 in total

1.  Association of Maternal Use of Triptans During Pregnancy With Risk of Attention-Deficit/Hyperactivity Disorder in Offspring.

Authors:  Gerd Marie Harris; Mollie Wood; Eivind Ystrom; Hedvig Nordeng
Journal:  JAMA Netw Open       Date:  2022-06-01

2.  Dispensing of benzodiazepines and benzodiazepine-related drugs to pregnant women: a population-based cohort study.

Authors:  Brit Solvor Riska; Svetlana Skurtveit; Kari Furu; Anders Engeland; Marte Handal
Journal:  Eur J Clin Pharmacol       Date:  2014-09-11       Impact factor: 2.953

3.  Hyperemesis gravidarum and long-term mortality: a population-based cohort study.

Authors:  S Fossum; Å V Vikanes; Ø Naess; L Vos; T Grotmol; S Halvorsen
Journal:  BJOG       Date:  2016-12-15       Impact factor: 6.531

4.  Long-term cardiovascular morbidity following hyperemesis gravidarum: A Norwegian nationwide cohort study.

Authors:  Stine Fossum; Øyvind Næss; Sigrun Halvorsen; Grethe S Tell; Åse V Vikanes
Journal:  PLoS One       Date:  2019-06-12       Impact factor: 3.240

5.  Identification of potential carcinogenic and chemopreventive effects of prescription drugs: a protocol for a Norwegian registry-based study.

Authors:  Bettina Kulle Andreassen; Nathalie C Støer; Jan Ivar Martinsen; Giske Ursin; Elisabete Weiderpass; G Hege Thoresen; Karen Boldingh Debernard; Øystein Karlstad; Anton Pottegard; Søren Friis
Journal:  BMJ Open       Date:  2019-04-08       Impact factor: 2.692

6.  Fertility treatment and oral contraceptive discontinuation for identification of pregnancy planning in routinely collected health data - an application to analgesic and antibiotic utilisation.

Authors:  Sarah Hjorth; Mollie Wood; Fatima Tauqeer; Hedvig Nordeng
Journal:  BMC Pregnancy Childbirth       Date:  2020-11-25       Impact factor: 3.007

7.  Glycated haemoglobin (HbA1c) in mid-pregnancy and perinatal outcomes.

Authors:  Ellen Ø Carlsen; Quaker Harmon; Maria C Magnus; Helle M Meltzer; Iris Erlund; Lars C Stene; Siri E Håberg; Allen J Wilcox
Journal:  Int J Epidemiol       Date:  2022-06-13       Impact factor: 9.685

8.  Vanishing twin syndrome among ART singletons and pregnancy outcomes.

Authors:  Maria C Magnus; Sara Ghaderi; Nils-Halvdan Morken; Per Magnus; Liv Bente Romundstad; Rolv Skjærven; Allen J Wilcox; Siri Eldevik Håberg
Journal:  Hum Reprod       Date:  2017-11-01       Impact factor: 6.918

9.  Birth and death notification via mobile devices: a mixed methods systematic review.

Authors:  Lavanya Vasudevan; Claire Glenton; Nicholas Henschke; Nicola Maayan; John Eyers; Marita S Fønhus; Tigest Tamrat; Garrett L Mehl; Simon Lewin
Journal:  Cochrane Database Syst Rev       Date:  2021-07-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.